A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...

By Gabriel Araujo SAO PAULO, Feb 24 (Reuters) - Brazilian planemaker Embraer announced on Tuesday new variants of its Praetor ...

Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.

Nandkumar M. Kamat In December 2019, a cluster of unusual pneumonia cases surfaced in Wuhan, China. Within weeks, the world ...

New guidance backs seasonal COVID-19 vaccination in immunocompromised patients. Read more on timing and risk groups.

With the CHMP affirmation, Moderna is on course to get EU approval for its fourth vaccine product and break new ground in ...

Approximately one in seven adults in the United States has kidney disease, where the organs responsible for filtering waste ...

Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market volatility kept investors ...

Emergency Care Reduction: The study of the 2024–2025 vaccine showed a 29.3% effectiveness (95% confidence interval [CI], 19.1 to 39.2) against Covid-19–related ED visits, preventing approximately 18.3 ...

Approximately one in seven adults in the United States has kidney disease, where the organs responsible for filtering waste ...

A groundbreaking study explains why certain COVID-19 vaccines caused dangerous blood clots, hemorrhages and VITT syndrome, ...

Across China, people have shared a growing number of stories about sudden deaths in adults who seemed healthy. Many reports focus on ages 30 to 50.